158 related articles for article (PubMed ID: 29206565)
21. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
23. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.
Zhang D; Raghavan N; Chen SY; Zhang H; Quan M; Lecureux L; Patrone LM; Lam PY; Bonacorsi SJ; Knabb RM; Skiles GL; He K
Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286
[TBL] [Abstract][Full Text] [Related]
24. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
26. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
Miao Z; Scott DO; Griffith DA; Day R; Prakash C
Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
[TBL] [Abstract][Full Text] [Related]
27. Absorption, Metabolism and Excretion of Surufatinib in Rats and Humans.
Li K; Ma S; Miao L; Fan S; Pan B; Zhang W; Su W; Xiong Y; Gu Z; Guo L; Sai Y
Curr Drug Metab; 2020; 21(5):357-367. PubMed ID: 32407271
[TBL] [Abstract][Full Text] [Related]
28. Absorption, distribution, metabolism and excretion of
Ma J; Ye Q; Northcutt V; Babiak J; Kong R
Xenobiotica; 2022 Dec; 52(12):1031-1040. PubMed ID: 36700425
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and excretion of an oral taxane analog, [14C]3'-tert-butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxy-paclitaxel (BMS-275183), in rats and dogs.
Ly VT; Caceres-Cortes J; Zhang D; Humphreys WG; Ekhato IV; Everett D; Cömezoğlu SN
Drug Metab Dispos; 2009 May; 37(5):1115-28. PubMed ID: 19196843
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and disposition of [(14)C]tivantinib after oral administration to humans, dogs and rats.
Murai T; Takakusa H; Nakai D; Kamiyama E; Taira T; Kimura T; Jimbo T; Bathala M; Pickersgill F; Zahir H; Tokui T; Savage RE; Ashwell MA; Izumi T
Xenobiotica; 2014 Nov; 44(11):996-1008. PubMed ID: 24911380
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
32. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
33. KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
Huskey SE; Zhu CQ; Fredenhagen A; Kühnöl J; Luneau A; Jian Z; Yang Z; Miao Z; Yang F; Jain JP; Sunkara G; Mangold JB; Stein DS
Drug Metab Dispos; 2016 May; 44(5):672-82. PubMed ID: 26921387
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
Mamidi RN; Cuyckens F; Chen J; Scheers E; Kalamaridis D; Lin R; Silva J; Sha S; Evans DC; Kelley MF; Devineni D; Johnson MD; Lim HK
Drug Metab Dispos; 2014 May; 42(5):903-16. PubMed ID: 24568888
[TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
36. Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humans.
Kogame A; Lee R; Pan L; Sudo M; Nonaka M; Moriya Y; Higuchi T; Tagawa Y
Xenobiotica; 2019 Apr; 49(4):433-445. PubMed ID: 29557709
[TBL] [Abstract][Full Text] [Related]
37. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
38. Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats.
Kim J; Wang R; Veverka KA; Dalton JT
Xenobiotica; 2013 Nov; 43(11):993-1009. PubMed ID: 24074268
[TBL] [Abstract][Full Text] [Related]
39. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
40. Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor.
Scheers E; Borgmans C; Keung C; Bohets H; Wynant I; Poggesi I; Cuyckens F; Leclercq L; Mamidi RNVS
Xenobiotica; 2021 Feb; 51(2):177-193. PubMed ID: 32902324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
